[Mullerian inhibiting substance type II receptor as a potential target for antineoplastic therapy].

Rak, A Ya

[Mullerian inhibiting substance type II receptor as a potential target for antineoplastic therapy]. [electronic resource] - Biomeditsinskaia khimiia Apr 2019 - 202-213 p. digital

Publication Type: Journal Article; Review

2310-6972

10.18097/PBMC20196503202 doi


Animals
Antineoplastic Agents--pharmacology
Cell Line, Tumor
Humans
Molecular Targeted Therapy
Neoplasms--drug therapy
Receptors, Peptide--metabolism
Receptors, Transforming Growth Factor beta--metabolism